Chemours (NYSE:CC) Rating Reiterated by UBS Group : vimarsan

UBS Group reaffirmed their neutral rating on shares of Chemours (NYSE:CC – Free Report) in a report published on Tuesday, Marketbeat Ratings reports. UBS Group currently has a $21.00 price target on the specialty chemicals company’s stock, down from their prior price target of $37.00. A number of other equities research analysts have also recently […]

Related Keywords

Sherbrooke , Quebec , Canada , United States , America , Asia Pacific , Invesco Ltd , Royal Bank , Jpmorgan Chase Co , Chemours Company , Jump Financial , Ubs Group , Sherbrooke Park Advisers , Specialized Solutions , Capital Management Inc , Capula Management Ltd , Free Report , Marketbeat Ratings , Management Ltd , Park Advisers , Get Free Report , North America , Middle East , Titanium Technologies , Advanced Performance , Chemours Daily ,